Jump to Navigation
Quantitative
Research
Quantitative Models
Methodology Graphic
EQR White Paper
Investment
Products
Sabrient QES Index Series
Baker's Dozen Model Portfolio
UITs
ETFs
Investor
Tools
Scorecards
Earnings Busters
Sector Detector
Advisors &
Individual Investors
Go to Investors Site
About Us
Our Company
Our People
ADV2A
Contact Us
Search form
Search
You are here:
You are here
Home
Fubo projects $90M-$100M pro forma adjusted EBITDA in fiscal 2026 while advancing Disney ad server monetization
Seeking Alpha
-
Wed, 08/05/2026 - 11:41
Gladstone Capital anticipates ~$75M quarterly originations while leverage rises to 100% of NAV
Seeking Alpha
-
Wed, 08/05/2026 - 11:41
Recursion outlines $375M 2026 cash OpEx guidance while advancing first Genentech neuroscience target
Seeking Alpha
-
Wed, 08/05/2026 - 11:41
Iron Mountain forecasts $7.94B-$8.01B 2026 revenue as ALM revenue approaches $1B
Seeking Alpha
-
Wed, 08/05/2026 - 11:41
Medline falls despite Q2 beat after cut to EBITDA outlook
Seeking Alpha
-
Wed, 08/05/2026 - 11:40
Match: No AI-Driven Makeover Can Save This Company
Seeking Alpha
-
Wed, 08/05/2026 - 11:40
Cementos Pacasmayo Public History Might Be Reaching Its End
Seeking Alpha
-
Wed, 08/05/2026 - 11:38
Google DeepMind CEO takes new position in company as Alphabet's chief scientist
Seeking Alpha
-
Wed, 08/05/2026 - 11:38
SpaceX: Looking Beyond The Hype
Seeking Alpha
-
Wed, 08/05/2026 - 11:35
Lord Abbett Affiliated Fund Q2 2026 Commentary
Seeking Alpha
-
Wed, 08/05/2026 - 11:35
Everus Construction Group, Inc. 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha
-
Wed, 08/05/2026 - 11:34
Regal Rexnord Corporation 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha
-
Wed, 08/05/2026 - 11:34
Heineken N.V. 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha
-
Wed, 08/05/2026 - 11:33
Circle outlines $310M-$330M 2026 other revenue, as Arc mainnet targets September 16 launch
Seeking Alpha
-
Wed, 08/05/2026 - 11:32
Phillips 66 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha
-
Wed, 08/05/2026 - 11:31
United Therapeutics anticipates potential 2027 approvals for ralinepag and Tyvaso IPF while holding 2026 revenue outlook unchanged
Seeking Alpha
-
Wed, 08/05/2026 - 11:31
Criteo forecasts 2026 contribution ex-TAC to decline 10% to 12% as it assumes no large-client spending recovery
Seeking Alpha
-
Wed, 08/05/2026 - 11:31
Royalty Pharma targets $3.4B-$3.5B 2026 portfolio receipts as it raises guidance again
Seeking Alpha
-
Wed, 08/05/2026 - 11:31
Champion Homes expects mid-single-digit Q2 revenue growth while excluding Homes Direct
Seeking Alpha
-
Wed, 08/05/2026 - 11:31
Clear outlines Q3 revenue of $284M-$287M while raising FY2026 free cash flow to at least $480M
Seeking Alpha
-
Wed, 08/05/2026 - 11:31
Pages
« first
‹ previous
…
2007
2008
2009
2010
2011
2012
2013
2014
2015
…
next ›
last »